Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
24.32 USD | -0.71% | +0.79% | -12.44% |
May. 02 | UBS Adjusts Price Target on Alkermes to $21 From $23, Maintains Sell Rating | MT |
May. 01 | Alkermes's Q1 Earnings, Revenue Grow But Miss Street View | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.44% | 4.14B | |
+28.77% | 49.18B | |
+0.97% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.80% | 26.09B | |
-22.13% | 18.71B | |
+7.94% | 13.26B | |
+32.50% | 12.32B | |
-0.40% | 11.99B |
- Stock Market
- Equities
- ALKS Stock
- News Alkermes plc
- Alkermes Names Caroline Loew Chief Executive Officer Designate of Planned Oncology Company